Firefly will utilize the grant to braden its production capacity and also to assess its microRNA assay.
MicroRNAs are a class of biomarkers which are used as indicators for early diagnosis of cancer and other diseases.
Firefly BioWorks co-founder and CTO Daniel Pregibon said they look forward to work with their academic and industry partners to develop research tools in this field.